Biotech startup NewLimit secures a major funding round after claiming a 'breakthrough discovery' of a prototype medicine that ...

A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

A team led by researchers has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of reprogrammed neurons found by other ...

NewLimit, which plans to take its young-again cell reprogramming therapy into the clinic next year, raised a $435 million ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...